A Unique Experience! Expo Pharma Milan 2024: Innovation and Connections for Our Clients

At Wexford, we don’t just focus on manufacturing formulations; we also strive to stay informed and up-to-date on everything happening in the global pharmaceutical field. Yes, at Wexford, we do the fieldwork for you! This year, we sent a team from Wexford Laboratories to one of the most prominent pharmaceutical expos in the world. The … Read more

Wexford Laboratories launches a new product, Ondansetron 4 mg/2 mL Injectable Solution, driven by high demand projections according to studies.

Wexford Laboratories now has available one of the most commonly used antiemetics for the treatment of Nausea and Vomiting: Ondansetron 4 mg/2 mL Injectable Solution, a product highly utilized by Oncologists and Surgeons. If you want to discover how our New Formulation can revitalize your product portfolio and help you stay at the forefront of … Read more

Dexketoprofen 50mg/2ml Injectable Solution: A New Option for Pain Relief

Wexford Laboratories Adds Dexketoprofen 50mg/2ml Injectable Solution to Its Product List, Offering Rapid and Effective Relief for Acute Pain March 2024: In a continuous effort to improve the quality of life for patients suffering from acute pain, Wexford Laboratories is proud to announce the launch of its new product: Dexketoprofen 50mg/2ml Injectable Solution. This innovative … Read more

Wexford announces approval of In Vitro Bioequivalence

Metformin is a widely prescribed medication used for the management of type 2 diabetes, a chronic disease that affects millions of people worldwide. It is an essential tool for controlling blood sugar levels and improving the overall health and well-being of individuals with diabetes. In vitro bioequivalence testing of Metformin is a crucial step in … Read more

Open chat
[caldera_form id="CF64ee16c372d21"]